Navigation Links
Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
Date:11/21/2007

First U.S. resolution to shine spotlight on crisis affecting 246 million

people worldwide

PRINCETON, N.J., Nov. 21 /PRNewswire-FirstCall/ -- On the eve of World Diabetes Day, leaders in the U.S. House of Representatives passed House Concurrent Resolution 211 supporting the goals and ideals of World Diabetes Day, which is recognized annually on November 14. Then, the next day, on World Diabetes Day itself, the U.S. Senate followed suit, passing Senate Resolution 382. More than 20 million Americans have diabetes, and that number is expected to double by 2025.

Passage of the U.S. resolution marks the first time Congress has officially supported World Diabetes Day since it was established in 1991 by the World Health Organization and the International Diabetes Federation, of which Novo Nordisk is a member. It represents an important milestone in a busy month of activities taking place as part of National Diabetes Month.

As the lead industry supporter of the resolution, Novo Nordisk and its National Changing Diabetes(R) Program have worked closely with many of the resolution sponsors, including Reps. Donald Payne (D-N.J.) and Donald Manzullo (R-Ill.) and Sens. Debbie Stabenow (D-Mich.), Pete Domenici (R-N.M.), Frank Lautenberg (D-N.J.) and Norman Coleman (R-Minn.) to help focus attention on diabetes and make the disease a top national health care priority.

"With over 80 years in diabetes care, Novo Nordisk commends the leadership and commitment of Representatives Payne and Manzullo and Senators Stabenow, Domenici, Lautenberg and Coleman, and the entire Congress. The attention and urgency these resolutions will bring to diabetes prevention and treatment efforts in the United States is a positive step forward in our shared passion of changing diabetes," said Martin Soeters, president of Novo Nordisk Inc.

The United Nations General Assembly passed a World Diabetes Day Resolution on December 20, 2006, rec
'/>"/>

SOURCE Novo Nordisk
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
2. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
3. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
4. FRC Applauds New Ballot Initiative for Cures Without Cloning
5. YM Biosciences announces adoption of renewed Shareholders Rights Plan
6. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
7. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
8. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
9. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
10. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
11. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...to also Visit Detroit , (... French Ambassador for International Investment, a..., , , , ,What: Ambassador Appia is available to m...iatives adopted by France to further develop the f...tion and development., , ,When: Available for Inte...
(Date:11/24/2009)...K, Iceland, November 24 ...ced that it has received notice from,the Nasdaq St...ock will be,suspended as of November 30, 2009 and ...d Exchange Commission, which will remove deCODE,s ...mpany files an appeal to the Nasdaq,Listing Qualif...
(Date:11/24/2009).../PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. anno...as allowed the patent application for,its nano-par...NOD technology is a highly efficient approach to i...nano-particles to enable oral delivery of drugs,ot... is a platform technology,that can be applied to m...
(Date:11/24/2009)...ently approved the Promega PowerPlex 16 HS System ...ting DNA records for the National DNA Index System...B) -- The FBI recently approved the Promega Power...rticipating in, or generating DNA records for, the...contains more than seven million profiles and has ...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...UVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Ph...ced preliminary results of a Phase 1 trial present...iety of Clinical Oncology (ASCO) Annual Meeting. P...X-427 was well tolerated as a monotherapy. In addi... tumor cells at all doses evaluated as well as evi...
... Several of LASIK and refractive eye surgery exp...hose eye doctors honored at the recent American So...nnual meeting in San Francisco, California. Dr. P... Trattler were on the winning team for the annual ...tition between two teams of refractive surgery exp...
... Martek Biosciences Corporation (Nasdaq: MATK ) ...8th Annual Needham Life Sciences Conference which ... New York Palace Hotel in New York City. Peter L....esent on Thursday, June 11, 2009, at 2:30 p.m. Eas...resentation can be accessed at: http://www.wsw...
Other Biology Technology:OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 2OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 3OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 4OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 5LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 2LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 3LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 4LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 5LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 6LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 7
(Date:11/25/2009)...rs recently received funding from the National Sci...ial to understanding the environment. The three gr...sistant professor in the Department of Biological ...te research projects. , His first project, title...nctions from the Leaf to the Landscape," will exam...
(Date:11/24/2009)...may help gut bacteria bind to the gastrointestinal...ducers to identify strains that are likely to be o...nteract with cells lining the gut to have a benefi... gut they are more likely to stick around long eno...e from the Institute of Food Research. IFR is an ...
(Date:11/24/2009)...ets of the earth,s history locked in its icy depth...information on the environments that have been sea...w, a team of researchers from nine institutions i...million dollars by the National Science Foundation...y. These scientists will drill through the West An...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2A second skin 10768 1Petascale computational tools could revolutionize understanding of genomic evolution 10766 1Petascale computational tools could revolutionize understanding of genomic evolution 10766 2Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 1Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 2Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 3Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 4
...roduction line, with conveyer belts carrying the d...en to be cooked. , Now imagine what would happen...d oozed as a blob onto the conveyor, misshapen, an...rmed, unbaked pretzels. The result: a mess. And if...en, the backup of messy dough in the system would ...
... New York Academy of Sciences, 7 World Trade Cente...10007 , The Malaria Research Institute at the Joh...he New York Academy of Sciences present Progress A...f-day symposium to highlight the latest research d...eeting will include discussions of new diagnostic ...
... struggle first observed in a species of North Ame...tive, the European common lizard. The two species ... of evolution, yet they share behavioral and repro...the males, according to new research published in ...available online. , The triangle of competing st...
Other Biology News:Botched production of insulin molecule may lead to diabetes 2Botched production of insulin molecule may lead to diabetes 3Botched production of insulin molecule may lead to diabetes 4Progress Against Malaria: Developments on the Horizon 2Three-way mating game of North American lizard found in distant European relative 2Three-way mating game of North American lizard found in distant European relative 3Three-way mating game of North American lizard found in distant European relative 4
Silencer Pre-designed siRNA, standard purity from Ambion
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Validated siRNA - with sequence information 5 nmol from Ambion
Biology Products: